Natural killer cells express clonally distributed receptors specific for major histocompatibility complex class I molecules. The human leukocyte antigen (HLA)-C-specific receptors have been molecularly identified and cloned. They exist not only as inhibitory (p58) but also as activatory (1050) receptors. Here we show that p50 and p58 are highly homologous in their extracellular regions formed by two Ig-like domains. In contrast, major differences exist in their transmembrane and cytoplasmic portions. Whereas p58 displays a 76-84-amino acid cytoplasmic tail containing an unusual antigen receptor activation motif, p50 is characterized by a shorter 39-amino acid tail. In addition, whereas p58 has a nonpolar transmembrane portion, p50 contains the charged amino acid Lys. These data strongly suggest that receptors with identical HLA-C allele specificity can mediate functions of opposite sign owing to their different transmembrane/cytoplasmic portions.
Summary
Natural killer cells express clonally distributed receptors specific for major histocompatibility complex class I molecules. The human leukocyte antigen (HLA)-C-specific receptors have been molecularly identified and cloned. They exist not only as inhibitory (p58) but also as activatory (1050) receptors. Here we show that p50 and p58 are highly homologous in their extracellular regions formed by two Ig-like domains. In contrast, major differences exist in their transmembrane and cytoplasmic portions. Whereas p58 displays a 76-84-amino acid cytoplasmic tail containing an unusual antigen receptor activation motif, p50 is characterized by a shorter 39-amino acid tail. In addition, whereas p58 has a nonpolar transmembrane portion, p50 contains the charged amino acid Lys. These data strongly suggest that receptors with identical HLA-C allele specificity can mediate functions of opposite sign owing to their different transmembrane/cytoplasmic portions.
T he cytolytic activity of NK cells is regulated by several clonally distributed inhibitory receptors specific for different groups of HLA class I andes. Interaction between these NK receptors and HLA class I molecules leads to inhibition of the NK-mediated target cell lysis (1--4) . The receptors specific for two distinct groups of HLA-C alleles have been molecularly identified as p58 molecules, which react with either GL183 (5) or EB6 mAb (6) . p58-encoding genes have recently been isolated and cloned (7) . They encode for type 1 transmembrane proteins, which belong to the Ig supeffamily. They are characterized by two extracellular Ig-hke domains and display a high level of sequence homology. Recently, additional 50-kD molecular forms of EB6 or GL183 mAb-reactive receptors have been identified. They display the same HLA-C allele specificity of the corresponding p58 receptors but mediate NK cell triggering rather than inhibition (8) . p50 receptors were found to be expressed only in some donors and to display a clonal distribution. Importantly, single NK cells did not coexpress p58 and p50 receptors with an identical HLA-C specificity (8) . The protein backbone of p58 or p50 molecules has been shown to be 42 and 36 kD, respectively, after deglycosylation. These data, together with identical HLA-C specificity and mAb reactivity, suggested that p58 and p50 could be homologous in their extracellular domains but different in their intracellular portions. Cloning of several p58-homologous genes revealed the existence of molecules displaying cytoplasmic tails of different length. Here we show that, different from p58, the activatory p50 receptors are characterized by a short intracytoplasmic tail associated with a transmembrane portion containing a polar residue.
Materials and Methods

Isolation of EB6 + or GL183 § NK Clones and Definition of the
Function of their Receptors. EB6 § or GL183 § NK cell clones were isolated as previously described (4) . Screening of clones for the expression of triggering (p50) or inhibitory (p58) receptors was performed by cytolytic tests using P815 target cells in a redirected killing assay. The HLA class I-negative 221 cells were transfected with Cw3 or Cw4 alleles as described in detail elsewhere (8) .
Amplification of Specific cDNAs fiom NK Cell Clones. Total RNA was extracted using RNAzol (Cinna/Biotecx, Friendswood, TX) by standard procedure, cDNA was obtained by reverse transcriptase (RT) reaction using oligo dT priming. Primers used for cDNA amplification were 5'-ACCTACAGATGCTTCGG (common up, nucleotides (nt) 583-599), 5'-AAAACACAGT-GATCCAATTA (C, nt. 913-932), and 5'-GTTCCG(CT)GTA-CACGATGA (E, nt. 986-1003). Each R T -P C R reaction contained 0.1 I-~M of control primers specific for the HLA-C locus [C1, 5'-GACG(AC)CG(AC)GAGTCC(AG)AGAGG; and C2, 5'-CG(GT)CCTCGCTCTGGTTGTAG] and 0.5 IxM of groupspecific primers. The set of primers common up/C was used in a 30-cycle PCR, including 15 cycles at 30 s at 94~ 30 s at 60~ and 30 s at 72~ and 15 cycles of 30 s at 94~ 30 s at 50~ and 30 s at 72~ followed by a final extension of 7 rain at 72~ PCR using the primer pair common up/E was carried out for 30 cycles of 30 s at 94~ 30 s at 60~ and 30 s at 72~ followed by a final extension of 7 rain at 72~ cDNA fragments were subcloned into pCRII vector (Invitrogen, San Diego, CA) and sequenced. Isolation of Full-Length cDNAs. The sequences of the forward primers used to obtain complete open reading frame (ORF) amplification products were 5'-ATGTCGCTCATGGTCG (SP1), 5'-ATGTCGCTCATGGTCATCAT (SP2), and 5'-ATGTCG-CTCTTGTTCG (SP3). The PCR cycling condition used for the sets of primers SP1/C, SP2/C, and SP3/C was 15 cycles of 20 s at 94~ 30 s at 60~ 30 s at 72~ followed by 15 cycles of 20 s at 94~ 30 s at 55~ and 30 s at 72~ followed by a final extension of 7 rain at 72~ 5' end nucleotide sequences of EB6-ActI and i83-ActI cDNAs were checked by rapid amplification ofcDNA ends (RACE) (9) .
Dot Blot
Transient Transfectants. The monkey COS cell line (5 • 105/ plate) was transfected by the DEAE-dextran method with different cDNA constructs (10): RSV.5gpt/c147.11, RSV.5gpt/EB6-ActI, RSV.5gpt/c16.11, and RSV.5gpt/183-ActI. After 48 h, transfectants were trypsinized, stained with EB6 or GL183 mAb, followed by a PE-conjugated goat antibody to mouse IgG1, and analyzed by a FACSort | (Becton Dickinson & Co., Mountain View, CA).
Stable Transfectants. Jurkat cells (2 • 107) were transfected by electroporation (960 IxF/250 V) with the cDNA construct RSV.5gpt/c142 or RSV.5gpt/EB6-ActI. 48 h after electroporation, cells were selected in mycophenolic acid and xantine-containing medium (10 ~g/ml each). 3-4 wk later, cells were analyzed for cell surface expression ofp58/p50 molecules.
Immunoprecipitation and Deglycosylation Experiments. Jurkat transfectants were lysed in 1% NP-40 lysis buffer and immunoprecipitated with EB6 mAb coupled to CNBr-Sepharose. Samples were fractionated in a 8.5% SDS-PAGE, blotted on a polyvinylidene difluoride membrane, and analyzed by Western blot with 12sI-EB6 mAb (8) . Surface 12SI-labeled (lactoperoxidase)Jurkat transfectants were lysed in 1% NP-40 and immunoprecipitated with EB6 mAb coupled with CNBr-Sepharose. Undigested or N-glycanase-digested molecules were analyzed on SDS-PAGE (8).
Results and Discussion
p58 and p50 Receptors Correlate with Different Types of Transmembrane and Intracytoplasmic Portions. N K cell clones
expressing either the activatory (p50) or the inhibitory (p58) form of EB6 or GL183 mAb-reactive receptor were used to analyze whether a correlation exists between the receptor function and the type oftransmembrane/cytoplasmic portion. To this end, a panel of P C R primers specific for unique sequences of genes encoding for either short or long cytoplasmic tails has been designed. The P C R primers used included (a) a c o m m o n forward primer annealing at the 5' end of the sequences encoding for the transmembrahe portions (common up); (b) a backward primer specific for the short (39-amino acid) tail (primer C); and (c) a backward primer specific for the long (76-84-amino acid) tail (primer E). The c o m m o n u p / C primer combination was found to amplify a 350-bp fragment, whereas the comm o n up/E combination amplified a 421-bp fragment. In N K clones expressing pS0 receptors (either EB6 or GL183), a 350-bp fragment was consistently amplified by the comm o n u p / C primer combination. In contrast, in clones expressing p58 receptors, the 421-bp fragment was always amplified by the c o m m o n up/E primer combination ( 1I) clone A4.12 (p58 GL183); (lanes 6 and 12) clone A1.20 (p58 GL183). As control, a 160-bp HLA-C fragment was coamplified. (B) The common up/C amplified fragments from the NK clones 1:82G16, 2:PA4, and 3:DF were hybridized with K-Lys, K4, and K2 probes, whereas the common up/E cDNAs amplified from the NK clones 10:1 F32, 11:A4.12, and 12:A1.20 were hybridized only with K-Lys. (Fig. 1 B) . selected activatory N K clones (either EB6 + or GL183 +) to obtain the complete O R F of the corresponding genes. To this end, based on the known sequences of the genes coding for p58 molecules, three forward primers (SP1, SP2, and SP3) specific for different signal peptide sequences were designed and used in combination with the backward primer C. By using the primer combination SP1/C, an amplified product of 932 bp was obtained exclusively from N K clones expressing the p50 EB6 or GL183 activatory receptors. The products amplified from two representative clones (PA4 and DF), termed EB6-ActI and 183-ActI, respectively, were subcloned in the pCP,.II vector and sequenced. In Fig. 3 , these sequences are compared with the several known p58 sequences.
Isolation of Full-Length cDNAs
Activatory EB6 and GLI83 Molecules Differ in their Transmembrane Portions.
Probes specific for the regions flanking the AAA Lys codon of either EB6-ActI (K4) or 183-ActI (K2) were further designed. K2 and K4 probes were hybridized with the common u p / C PCR-amplified products obtained from a panel of N K clones expressing p50 EB6 or GL183 activatory receptors. A precise correlation was found between hybridization with K2 or K4 probes and the EB6 or GL183 phenotype. Fig. 1 B shows the results obtained in three representative N K cell clones. It is evident that the K4 probe only hybridized with the common u p / C P C R products derived from the p50/EB6 + cell clones. Conversely, the K2 probe only hybridized with that derived from the p50/GL183 + cell clone.
MAb Reactivity with COS Transient Cell Transfectants.
183-ActI and EB6-ActI cDNAs were subcloned in the pRSV.5gpt expression vector (10) and transiently transfected in COS cells. EB6-Actl transfectants were found to react with EB6 but not with GL183 mAb, whereas 183-ActI transfectants were stained by GL183 but not by EB6 mAb (Fig. 2 A) . In both transfectants, 50-kD molecules were revealed by immunoprecipitation experiments, followed by Western blot, using either EB6 or GL183 mAbs. Conversely, 58-kD molecules were immunoprecipitated from COS cells transfected with either 47.11 or 6.11 cDNAs (data not shown) (7), coding for p58 EB6 or GL183 inhibitory receptors, respectively (not shown).
Sequence Alignment of Different p50 and p58 Receptors.
EB6-ActI and 183-ActI cDNAs were compared with the previously described GL183 and EB6 c D N A sequences (not shown). EB6-ActI did not correspond to any of the known sequences, whereas 183-ActI was highly homologous to the previously described clone 49 (7). However, the O R F of the 183-ActI c D N A encodes for a protein containing, at residue 20, Gly instead of Trp. In addition, it encodes for three additional amino acids (Met-Ser-Leu) at the N H 2 terminus (Fig. 3) , which appear to be critical for an efficient expression of GL183 molecules (data not shown). Alignment of all known p58-related amino acid sequences also indicated that the extracellular regions of both EB6 and GL183 molecules are highly homologous. However, at least 11 amino acid residues in the extracellular domains were unique to EB6 or GL183 molecules. 8 of these residues were localized in the more external Ig-like domain. Both 183-ActI-and EB6-ActI-encoded proteins displayed a 39-amino acid cytoplasmic tail. Moreover, they shared four unique residues in their transmembrane portions (one represented by Lys) not present in molecules characterized by the 7 6 / 8 4 -A A tails.
Biochemical Analysis of p50 /p58 Molecules Expressed by Jurkat Cell Transfectants.
To characterize further the p50 or p58 molecules encoded by EB6-ActI and EB6-c142 cDNAs and reactive with EB6 mAb, stable transfectants were generated in Jurkat cells using RSV.5gpt constructs. Both transfectants were brightly stained by EB6 but not by GL183 mAb (Fig. 2 B) . In addition, EB6 mAb immuno-precipitated 50-kD molecules from EB6-ActI cell transfectants and 58-kD molecules from EB6-c142 transfectants (Fig. 4 A) . In addition, N-glycanase digestion resulted in molecules of 36 and 42 kD, respectively, in agreement with previous data on EB6 activatory or inhibitory molecules expressed by N K cell clones (8) (Fig. 4 B) .
These data indicate that the HLA-C--specific N K receptors that mediate either cell triggering or inhibition display a high sequence homology in their extracellular domains, but not in their transmembrane or cytoplasmic portions. Therefore, receptors with identical specificity and mAb reactivity may transduce signals o f opposite sign because of structural differences in the portions involved in signal transduction.
The finding that 11 amino acid residues in the extracellular domains are unique to EB6 or GL183 receptors may be related to the different H L A -C allele specificity and mAb reactivity. O n the other hand, the activatory and inhibitory receptors reacting with the same anti-p58 mAb only differed for 2-7 residues in their extracellular domains. In contrast, major differences existed in their transmembrahe and cytoplasmic portions. Thus, only the transmembrane portion o f the activatory receptor contained a polar (Lys) residue, in association with a 39-amino acid intracytoplasmic tail. This residue in the transmembrane portion o f p50 molecules represents a potential site of association with proteins involved in signal transduction. The inhibitory form is characterized by a 76-84-amino acid tail containing an antigen receptor activation motif (ARAM)-like motif characterized by tandem Tyr-X-X-Leu sequences spaced by 26 amino acids. Notably, in the typical ARAMs present in the TCR-associated CD3 chains, the T y r -X -XLeu sequences are spaced by 6-8 amino acid residues (11) . In contrast, the 39-amino acid form did not contain the ARAM-like motif because o f an in-frame stop codon within the first Tyr-X-X-Leu sequence. These data suggest that different molecules involved in signal transduction may be associated to the activatory or inhibitory H L A -Cspecific receptors. It will be o f interest to analyze whether N K receptors specific for other M H C class I molecules display similar structural characteristics. In this context, differing experimental evidence in rat and mouse suggests that MHC-class I-specific receptors may also deliver triggering signals (12, 13) . In addition, signaling via CD94, the putative Bw6-specific human N K receptor, resulted in either N K cell triggering or inhibition (14) .
